WO1994010316B1 - Lipoproteine a de la membrane exterieure de l'actinobacillus pleuropneumoniae et utilisations - Google Patents

Lipoproteine a de la membrane exterieure de l'actinobacillus pleuropneumoniae et utilisations

Info

Publication number
WO1994010316B1
WO1994010316B1 PCT/CA1993/000448 CA9300448W WO9410316B1 WO 1994010316 B1 WO1994010316 B1 WO 1994010316B1 CA 9300448 W CA9300448 W CA 9300448W WO 9410316 B1 WO9410316 B1 WO 9410316B1
Authority
WO
WIPO (PCT)
Prior art keywords
outer membrane
actinobacillus pleuropneumoniae
protein
amino acid
acid sequence
Prior art date
Application number
PCT/CA1993/000448
Other languages
English (en)
Other versions
WO1994010316A1 (fr
Filing date
Publication date
Priority claimed from US07/971,558 external-priority patent/US5441736A/en
Application filed filed Critical
Priority to DE69333365T priority Critical patent/DE69333365T2/de
Priority to DK93923430T priority patent/DK0669984T3/da
Priority to EP93923430A priority patent/EP0669984B1/fr
Priority to CA002148369A priority patent/CA2148369C/fr
Publication of WO1994010316A1 publication Critical patent/WO1994010316A1/fr
Publication of WO1994010316B1 publication Critical patent/WO1994010316B1/fr

Links

Abstract

L'invention concerne de nouveaux vaccins s'utilisant contre l'Actinobacillus pleuropneumoniae. Les vaccins contiennent au moins une lipoprotéine A de la membrane extérieure d'Actinobacillus pleuropneumoniae ou un de ces fragments immunogènes. L'invention concerne également des séquences d'ADN codant lesdites protéines, des vecteurs comprenant lesdites séquences et des cellules hôtes transformées au moyen desdits vecteurs. On peut utiliser les vaccins pour traiter ou prévenir des infections respiratoires porcines.
PCT/CA1993/000448 1992-11-05 1993-11-03 Lipoproteine a de la membrane exterieure de l'actinobacillus pleuropneumoniae et utilisations WO1994010316A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE69333365T DE69333365T2 (de) 1992-11-05 1993-11-03 Lipoprotein a der äusseren membran von actinobacillus pleuropneumonia und dessen verwendung
DK93923430T DK0669984T3 (da) 1992-11-05 1993-11-03 Lipoprotein A fra den ydre membran i Actinobacillus pleuropneumoniae og anvendelser deraf
EP93923430A EP0669984B1 (fr) 1992-11-05 1993-11-03 Lipoproteine a de la membrane exterieure de l'actinobacillus pleuropneumoniae et utilisations
CA002148369A CA2148369C (fr) 1992-11-05 1993-11-03 Lipoproteine a de membrane externe d'actinobacillus pleuropneumoniae; son utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/971,558 US5441736A (en) 1992-11-05 1992-11-05 Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof
US07/971,558 1992-11-05

Publications (2)

Publication Number Publication Date
WO1994010316A1 WO1994010316A1 (fr) 1994-05-11
WO1994010316B1 true WO1994010316B1 (fr) 1994-07-21

Family

ID=25518543

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1993/000448 WO1994010316A1 (fr) 1992-11-05 1993-11-03 Lipoproteine a de la membrane exterieure de l'actinobacillus pleuropneumoniae et utilisations

Country Status (10)

Country Link
US (2) US5441736A (fr)
EP (1) EP0669984B1 (fr)
CA (1) CA2148369C (fr)
CY (1) CY2594B2 (fr)
DE (1) DE69333365T2 (fr)
DK (1) DK0669984T3 (fr)
ES (1) ES2213144T3 (fr)
PT (1) PT669984E (fr)
TW (1) TW241267B (fr)
WO (1) WO1994010316A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US6713071B1 (en) * 1998-10-22 2004-03-30 Pfizer Inc. Proteins from actinobacillus pleuropneumoniae
TWI224107B (en) * 1998-10-22 2004-11-21 Pfizer Prod Inc Novel proteins from actinobacillus pleuropneumoniae
DE60017211T2 (de) 1999-02-17 2005-06-02 Pfizer Products Inc., Groton Fusionsproteine mit Trägern welche eine doppelte Immunantwort induzieren
GB9914870D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Sa Novel compounds
US7076437B1 (en) 1999-10-29 2006-07-11 Victor Levy Process for consumer-directed diagnostic and health care information
KR100693077B1 (ko) 2005-11-03 2007-03-12 채찬희 돼지 복합 호흡기 질환 예방 및 치료용 생물학적 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2108693T3 (es) * 1990-04-05 1998-01-01 Univ Saskatchewan Compuestos y tratamientos para la neumonia en animales.
US6656477B1 (en) * 1992-07-28 2003-12-02 Board Of Trustees Of Michigan State University 43 Kd protein vaccine and method for the production thereof

Similar Documents

Publication Publication Date Title
JP3429313B2 (ja) 中耳炎ワクチン
US4985243A (en) Composition and method for protecting against diseases caused by microorganisms
CA2102208A1 (fr) Domaines de liaison dans les proteines notch et delta
GB9224584D0 (en) Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
CA2143491A1 (fr) Nouveau peptide lie a l'apoptose humaine et adn codant ledit peptide
CA2395499A1 (fr) Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations
CA2385325A1 (fr) Antigenes de chlamydia, fragments d'adn correspondants et utilisations
CA2217522A1 (fr) Molecule isolee d'acide nucleique de proteine b regulee par fe (frpb) et vaccin utilisant cette molecule
CA2215328A1 (fr) Nouvelles sequences d'adn du cytomegalovirus humain
WO1994010316B1 (fr) Lipoproteine a de la membrane exterieure de l'actinobacillus pleuropneumoniae et utilisations
JP2002542169A (ja) Clostridiumdifficileに対する、組換え毒素A/毒素Bワクチン
DK149778B (da) Analogifremgangsmaade til fremstilling af des-pheb1-humaninsulin eller derivater deraf
CA2413576A1 (fr) Antigenes de streptococcus pyogenes
CA2171611A1 (fr) Analogue d'haemophilus hin47 a activite protease reduite
Egelseer et al. Characterization of an S-layer glycoprotein produced in the course of S-layer variation of Bacillus stearothermophilu s ATCC 12980 and sequencing and cloning of the sbsD gene encoding the protein moiety
CA2222701A1 (fr) Facteur camp du streptococcus uberis
CA2180309A1 (fr) Vaccin contre la coccidiose de la volaille
EP0603406B1 (fr) Antigene de mycoplasme aviaire, son gene, vecteur recombine contenant ledit gene, et vaccin prepare a l'aide de celui-ci
AU6995291A (en) Recombinant coccidiosis vaccines -5-7 eimeria surface antigen
CA2423616A1 (fr) Mutants de chimiokines intervenant dans le traitement de la sclerose en plaques
AU626049B2 (en) Method for preparing vaccine for dental caries and vaccinal compositions for dental caries used as nasal drop
JPH0195791A (ja) 新規なポリペプチド、その製法、そのためのベクター及びそれを含有する医薬
IE870220L (en) Human lymphotoxin polypeptide derivatives
HU219762B (hu) Neisseria meningitidis fertőzések elleni alegység vakcina és a megfelelő tisztított alegységek
AU622446B2 (en) A monoclonal antibody against pseudomonas aeruginosa, the preparation and use thereof